Johnson M A, Fischer A B, Chen K W. "一种的合成方法" [P]. US Patent, US 10679603 B2, 2023-04-18.
发明人罗永刚,马晓峰,唐晓军. "Method for the Synthesis of 2-(1h-Indol-3-yl)-N-(1,3,4-thiadiazol-2-yl)acetamide" [P]. 中国发明专利, 专利号 CN 112752426 B, 授权公告日 2025-08-28.
发明人沈红梅,朱建伟,李文辉. "A Process for Preparing High-Purity 2-(1h-Indol-3-yl)-N-(1,3,4-thiadiazol-2-yl)acetamide" [P]. 中国发明专利, 专利号 CN 113873045 B, 授权公告日 2024-08-07.
参考文献 Literature
Martinez C, Lopez D R. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Chromatographia, 2017, 1358, 9767-9779.
Jensen P, Larsen A M, Olsen K. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". J. Nat. Prod., 2011, 1994, (10), 149-157.
Yamamoto K, Tanaka H, Suzuki T. "Identification and Structural Characterization of a Novel Degradation Product of 2-(1h-Indol-3-yl)-N-(1,3,4-thiadiazol-2-yl)acetamide Using HRMS and NMR". Anal. Chim. Acta, 2011, 1258, (12), 6030-6048.
Xu M, Hu Y, Zhou D. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Sci. Total Environ., 2022, 160, (11), 8066-8093.